San Ysidro Health Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2003
NCT00066950
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

San Ysidro Health Center

Active Ingredients

Drugs in Phase 3 Trials (2)

chlorhexidine (hibitane) (1 trial)

sodium fluoride (18F) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dental Caries (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2